Wealth Enhancement Advisory Services, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $65.4 Billion
- Q4 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 18,961 shares of ARWR stock, worth $782,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,961
Previous 15,083
25.71%
Holding current value
$782,330
Previous $520,000
50.38%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ARWR
# of Institutions
345Shares Held
103MCall Options Held
953KPut Options Held
263K-
Vanguard Group Inc Valley Forge, PA16MShares$662 Million0.01% of portfolio
-
Black Rock Inc. New York, NY15.7MShares$647 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.9MShares$450 Million5.14% of portfolio
-
State Street Corp Boston, MA6.4MShares$264 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.98MShares$206 Million3.21% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.37B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...